Coadministration of clozapine and fluvoxamine in psychotic patients - Clinical experience

Pharmacopsychiatry

Volumn 32, Issue 2, 1999, Pages 76-77

  Lammers, C H ^a   Deuschle, M ^a,c   Weigmann, H ^b   Hartter S ^b   Hiemke, C ^b   Heese, C ^a   Heuser, I ^a  

^a MAX PLANCK INSTITUTE OF PSYCHIATRY   (Germany)

^b JOHANNES GUTENBERG UNIVERSITY   (Germany)

^c CENTRAL INSTITUTE OF MENTAL HEALTH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CLOZAPINE; CLOZAPINE N OXIDE; DRUG METABOLITE; FLUVOXAMINE; NORCLOZAPINE; UNCLASSIFIED DRUG;

ADULT; ALERTNESS; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; COGNITION; DRUG BLOOD LEVEL; DRUG METABOLISM; DRUG MONITORING; DRUG RESPONSE; FEMALE; HUMAN; MALE; PRIORITY JOURNAL; PSYCHOSIS; SEDATION; SIDE EFFECT;

EID: 0032918565     PISSN: 01763679     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2007-979196     Document Type: Article

References (10)

1. Bertilsson, L., J. Antonio, M. L. Dahl, A. Llerena, C. Alm, U. Bondesson, L. Lindström, I. Rodriguez de la Rubia, S. Ramos, J. Benitez: Clozapine disposition covaries with CYP1 A2 activity determined by a caffeine test. British Journal of Clinical Pharmacology 38 (1994) 471-473
2. Brasen, K., E. Skjelbo, B. Rasmussen, H. Poulsen, S. Loft: Fluvoxamine is a potent inhibitor of cytochrome P4501 A2. Biochemical Pharmacology 45 (1993) 1211-1214
3. Centorrino, F., R. Baldessarini, F. Frankenburg, J. Kando, S. Volpicelli, J. Flood: Serum levels of clozapine and norclozapine in patients treated with selective serotonin reuptake inhibitors. American Journal of Psychiatry 153 (1996) 820-822
4. Dumortier, G., A. Lochu, P. Colen de Melo, O. Ghribi, D. Roche Rabreau, K. Degrassat, J. M. Desce: Elevated clozapine plasma concentrations after fluvoxamine initiation. American Journal of Psychiatry 153 (1996) 738-739
5. Hiemke, C., H. Weigmann, S. Härrter, N. Dahmen, H. Wetzel, H. Müller: Elevated levels of clozapine in serum after addition of fluvoxamine. Journal of Clinical Psychopharmacology 14 (1994) 279-281
6. Koponen, H. J., E. Leinonen, U. Lepola: Fluvoxamine increases the clozapine serum levels significantly. European Neuropsychopharmacology 6 (1996) 69-71
7. Miller, D. D., F. Fleming, T. L. Holman, P. J. Perry: Plasma clozapine concentrations as a predictor of clinical response: a follow-up study. Journal of Clinical Psychiatry 55 (Suppl. 8) (1994) 117-121
8. Satzger W., R. R. Engel: Der computerisierte Gedächtnis- und Aufmerksamkeitstest (München). Beltztest, Göttingen, Germany (1992)
9. Szegedi A., J. Wiesner, C. Hiemke: Improved efficacy and fewer side effects under clozapine treatment after addition of fluvoxamine. Journal of Clinical Psychopharmacology 15 (1995) 141-143
10. Zimmermann, P., B. Fimm: Testbatterie Aufmerksamkeitsprüfung (TAP), Version 1.02. Psytest, Freiburg, Germany (1993)